TW201515666A - Multi-stage releasing composite particles containing amino acid marine active factor peptides and manufacturing method thereof - Google Patents
Multi-stage releasing composite particles containing amino acid marine active factor peptides and manufacturing method thereof Download PDFInfo
- Publication number
- TW201515666A TW201515666A TW102138235A TW102138235A TW201515666A TW 201515666 A TW201515666 A TW 201515666A TW 102138235 A TW102138235 A TW 102138235A TW 102138235 A TW102138235 A TW 102138235A TW 201515666 A TW201515666 A TW 201515666A
- Authority
- TW
- Taiwan
- Prior art keywords
- peptide
- amino acid
- ionic
- space
- particle
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 231
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 118
- 239000011246 composite particle Substances 0.000 title claims abstract description 104
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- 238000005728 strengthening Methods 0.000 claims abstract description 4
- 235000001014 amino acid Nutrition 0.000 claims description 116
- 229940024606 amino acid Drugs 0.000 claims description 116
- 239000002131 composite material Substances 0.000 claims description 53
- 239000011859 microparticle Substances 0.000 claims description 50
- 239000002245 particle Substances 0.000 claims description 48
- 108010035532 Collagen Proteins 0.000 claims description 42
- 102000008186 Collagen Human genes 0.000 claims description 39
- 229920001436 collagen Polymers 0.000 claims description 39
- 239000007788 liquid Substances 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 28
- 235000010755 mineral Nutrition 0.000 claims description 27
- 239000011707 mineral Substances 0.000 claims description 27
- 239000002612 dispersion medium Substances 0.000 claims description 25
- 230000002209 hydrophobic effect Effects 0.000 claims description 25
- 238000011049 filling Methods 0.000 claims description 23
- 125000001165 hydrophobic group Chemical group 0.000 claims description 23
- 238000012423 maintenance Methods 0.000 claims description 22
- 230000009920 chelation Effects 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 20
- 239000001257 hydrogen Substances 0.000 claims description 19
- 229910052739 hydrogen Inorganic materials 0.000 claims description 19
- 239000011573 trace mineral Substances 0.000 claims description 18
- 235000013619 trace mineral Nutrition 0.000 claims description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 17
- 125000003010 ionic group Chemical group 0.000 claims description 15
- 210000001519 tissue Anatomy 0.000 claims description 15
- 239000013522 chelant Substances 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 13
- -1 glycine Amino acids Chemical class 0.000 claims description 12
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 11
- 239000010949 copper Substances 0.000 claims description 11
- 239000004475 Arginine Substances 0.000 claims description 10
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 10
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 10
- 230000004888 barrier function Effects 0.000 claims description 10
- 150000002500 ions Chemical class 0.000 claims description 10
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 9
- 239000004472 Lysine Substances 0.000 claims description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- 230000003796 beauty Effects 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 8
- 239000000945 filler Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 229910052712 strontium Inorganic materials 0.000 claims description 7
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 7
- 239000011701 zinc Substances 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 6
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 6
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 230000001914 calming effect Effects 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 230000002708 enhancing effect Effects 0.000 claims description 6
- 229910052744 lithium Inorganic materials 0.000 claims description 6
- 229910052750 molybdenum Inorganic materials 0.000 claims description 6
- 239000011733 molybdenum Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 230000003014 reinforcing effect Effects 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- 241000251468 Actinopterygii Species 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 5
- 241000243142 Porifera Species 0.000 claims description 5
- 241000243169 Spongillidae Species 0.000 claims description 5
- 235000003704 aspartic acid Nutrition 0.000 claims description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 5
- 239000002609 medium Substances 0.000 claims description 5
- 239000003094 microcapsule Substances 0.000 claims description 5
- 230000003020 moisturizing effect Effects 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 230000002087 whitening effect Effects 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 229910052684 Cerium Inorganic materials 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 230000004308 accommodation Effects 0.000 claims description 4
- 238000005842 biochemical reaction Methods 0.000 claims description 4
- 210000000988 bone and bone Anatomy 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 4
- 229960000310 isoleucine Drugs 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 230000001815 facial effect Effects 0.000 claims description 3
- 239000004474 valine Substances 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- LQRJAEQXMSMEDP-XCHBZYMASA-N peptide a Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)NCCCC[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)C(\NC(=O)[C@@H](CCCCN)NC(=O)CNC(C)=O)=C/C=1C=CC=CC=1)C(N)=O)C(=O)C(\NC(=O)[C@@H](CCCCN)NC(=O)CNC(C)=O)=C\C1=CC=CC=C1 LQRJAEQXMSMEDP-XCHBZYMASA-N 0.000 claims description 2
- 235000013930 proline Nutrition 0.000 claims description 2
- 229910052792 caesium Inorganic materials 0.000 claims 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 claims 1
- 238000000502 dialysis Methods 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 36
- 239000013535 sea water Substances 0.000 description 16
- 238000013461 design Methods 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 150000001944 cysteine derivatives Chemical class 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000002344 surface layer Substances 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 240000002853 Nelumbo nucifera Species 0.000 description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000002296 dynamic light scattering Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 2
- 235000003880 Calendula Nutrition 0.000 description 2
- 240000001432 Calendula officinalis Species 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 235000010254 Jasminum officinale Nutrition 0.000 description 2
- 240000005385 Jasminum sambac Species 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- 241000333181 Osmanthus Species 0.000 description 2
- 235000019082 Osmanthus Nutrition 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003537 Vitamin B3 Natural products 0.000 description 2
- 229930003571 Vitamin B5 Natural products 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229930003756 Vitamin B7 Natural products 0.000 description 2
- 229930003761 Vitamin B9 Natural products 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 239000000576 food coloring agent Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
- 108010091748 peptide A Proteins 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 235000009492 vitamin B5 Nutrition 0.000 description 2
- 239000011675 vitamin B5 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000011912 vitamin B7 Nutrition 0.000 description 2
- 239000011735 vitamin B7 Substances 0.000 description 2
- 235000019159 vitamin B9 Nutrition 0.000 description 2
- 239000011727 vitamin B9 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JQJSFAJISYZPER-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(2,3-dihydro-1h-inden-5-ylsulfonyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NS(=O)(=O)C1=CC=C(CCC2)C2=C1 JQJSFAJISYZPER-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical class CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- IIUKYVDDRJWLJF-UHFFFAOYSA-N 2-decyloctadecanoic acid Chemical class CCCCCCCCCCCCCCCCC(C(O)=O)CCCCCCCCCC IIUKYVDDRJWLJF-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- NZXZINXFUSKTPH-UHFFFAOYSA-N 4-[4-(4-butylcyclohexyl)cyclohexyl]-1,2-difluorobenzene Chemical compound C1CC(CCCC)CCC1C1CCC(C=2C=C(F)C(F)=CC=2)CC1 NZXZINXFUSKTPH-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- IBYCEACZVUOBIV-UHFFFAOYSA-N 4-methylpentyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCC(C)C IBYCEACZVUOBIV-UHFFFAOYSA-N 0.000 description 1
- AUGIYYGVQDZOLU-UHFFFAOYSA-N 4-methylpentyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCC(C)C AUGIYYGVQDZOLU-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- GHDOSRJUUZHFIV-UHFFFAOYSA-N CCCCCCCCCCC(CCCCC)(CCCCCC)CCCCCC Chemical compound CCCCCCCCCCC(CCCCC)(CCCCCC)CCCCCC GHDOSRJUUZHFIV-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 240000004045 Cassia javanica Species 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 235000003368 Ilex paraguariensis Nutrition 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 241000973598 Oxyjulis californica Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229940122985 Peptide agonist Drugs 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- CMCJFUXWBBHIIL-UHFFFAOYSA-N Propylene glycol stearate Chemical class CC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CMCJFUXWBBHIIL-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 241001092387 Spiraea Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 235000008109 Thuja occidentalis Nutrition 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 244000178289 Verbascum thapsus Species 0.000 description 1
- 235000010599 Verbascum thapsus Nutrition 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- 235000012544 Viola sororia Nutrition 0.000 description 1
- 241001106476 Violaceae Species 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003342 alkenyl group Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- IUGNTDSUZLPSOK-UHFFFAOYSA-N bis(4-methylpentyl) hexanedioate Chemical compound CC(C)CCCOC(=O)CCCCC(=O)OCCCC(C)C IUGNTDSUZLPSOK-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910001430 chromium ion Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- YXMMAVURUUXKKN-UHFFFAOYSA-J copper chlorophyll sodium Chemical compound [Na+].[Na+].[Cu+2].[N-]1C2=C(C=3C(C(C)C(=CC=4C(=C(C=C)C(=C5)N=4)C)N=3)CCC([O-])=O)C(C([O-])=O)C([O-])=C2C(C)=C1C=C1C(CC)=C(C)C5=N1 YXMMAVURUUXKKN-UHFFFAOYSA-J 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical class NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 150000001945 cysteines Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000021433 fructose syrup Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 235000020331 mate tea Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 238000003921 particle size analysis Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 150000003384 small molecules Chemical group 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
Description
本發明的技術領域係有關一種試用於保養組合物之含胺基酸海洋活性因子之多段釋放複合胜肽微粒,主要特徵在於該多段釋放複合胜肽微粒包含一用於架構多段釋放複合微粒空間之胜肽、複數個用於與該胜肽離子性螯合之離子性海洋活性因子及一用於強化複合微粒架構之胺基酸,其中該胜肽與離子性海洋活性因子螯合架構一個多段釋放複合微粒空間,該微粒空間具有親水性用來填置該胺基酸,並透過該胺基酸所提供的氫鍵強化胜肽與離子性海洋活性因子所螯合架構多段釋放複合微粒空間之結構。本發明的設計在於透過分子設計架構一微粒空間,並利用胜肽鍵、氫鍵及離子鍵使該微粒空間形成一個親水性空間,可容納親水性成份。本發明的設計所使用之離子性海洋活性因子係指取自深層海水並在生化反應中扮演輔助因子的多價微量元素金屬離子,來自深層海水所含微量元素具有豐富多元與均衡的特徵,對皮膚的鎮定、抑菌、消炎、排毒、美顏、抗衰老、提高免疫能力及人體細胞組織代謝修復都有重要的作用與功效。本發明所設計之關鍵離子性海洋活性因子,特別地是利用澳洲大堡礁海洋深層水或台灣東海岸海洋深層水水體。本發明含胺基酸海洋活性因子胜肽之多段釋放複合微粒,進一步可配合一選自由凝膠、顆粒懸浮液、均勻液、乳化液所 組成族群之組合的分散媒介體形成一用於醫學美容及保養之保養組成物。 The technical field of the invention relates to a multi-stage release composite peptide microparticle containing an amino acid-containing marine active factor which is used for the maintenance composition, and is mainly characterized in that the multi-stage release composite peptide microparticle comprises a space for constructing a multi-stage release composite particle space. a peptide, a plurality of ionic marine active factors for ionic chelation with the peptide, and an amino acid for reinforcing the composite particle structure, wherein the peptide and the ionic marine active factor chelate structure are released in multiple stages a composite particle space having a hydrophilicity for filling the amino acid and enhancing the structure of the multi-stage release composite particle space by the hydrogen bond-enhanced peptide and the ionic marine active factor chelation structure provided by the amino acid . The design of the invention consists in constructing a particle space through a molecular design structure, and using the peptide bond, the hydrogen bond and the ionic bond to form a hydrophilic space of the particle space, and can accommodate the hydrophilic component. The ionic marine active factor used in the design of the present invention refers to a multivalent trace element metal ion taken from deep seawater and acting as a cofactor in the biochemical reaction, and the trace elements contained in the deep seawater are rich in diversity and equilibrium characteristics. The skin's calming, antibacterial, anti-inflammatory, detoxification, beauty, anti-aging, improve immunity and metabolism and repair of human cell tissue have important functions and effects. The key ionic marine active factor designed by the invention, in particular, utilizes the deep water of the Great Barrier Reef in Australia or the deep water body of the ocean on the east coast of Taiwan. The multi-stage release composite microparticles containing the amino acid marine active factor peptide of the present invention may further be combined with one selected from the group consisting of a gel, a particle suspension, a homogeneous liquid and an emulsion. The dispersion medium comprising the combination of groups forms a maintenance composition for medical beauty and maintenance.
一般的保養品大多是使用在保養肌膚,給予肌膚自母體脫離後,因為外界環境所導致的氧化及老化所失去的彈性及活力,由於隨著年齡的增長,肌膚的彈性及活性會逐漸的衰退而不如新生兒般的嬌柔細膩,因此愛美的女性甚至男性多會購買保養品擦拭在肌膚上,以提供肌膚所需的營養,減少其老化並抗氧化。但是一般的保養品一般擦拭在肌膚表面,但由於皮膚表層疏水特性使許多親水性的活性營養成份大多難以進入皮膚組織,以使得肌膚的各毛細孔能夠充分的吸收保養品中所含之保養精華。因此,為了解決習知保養品配方技藝中無法有效經皮吸收的問題,先前技術進一步提出利用磷脂質來包覆活性成份達到經皮吸收的目的,磷脂質依來源有免疫、致敏及化學合成純化的問題,並且保存條件較為嚴苛,具有應用普及性的門檻。有鑑於習知技藝之各項問題,為了能夠兼顧解決,本發明提出一種含胺基酸海洋活性因子胜肽之多段釋放複合微粒,透過天然且人體必須元素與分子組成並架構一個容易經皮吸收並包覆親水性活性成份的複合性微粒,以作為改善上述缺點之實現方式與依據。根據本發明之目的所提出含胺基酸海洋活性因子胜肽之多段釋放複合微粒,其主要特徵在於該多段釋放複合胜肽微粒包含一用於架構多段釋放複合微粒空間之胜肽、複數個用於與該胜肽離子性螯合之離子性海洋活性因子及一用於強化複合微粒架構之胺基酸。 Most of the general care products are used to maintain the skin and give the skin its elasticity and vitality due to oxidation and aging caused by the external environment. As the age increases, the elasticity and activity of the skin gradually decline. It is not as delicate and delicate as a newborn, so women who love beauty and even men will buy skin care products to wipe the skin to provide the nutrients needed by the skin, reduce its aging and resist oxidation. However, general skin care products are generally wiped on the surface of the skin, but due to the hydrophobic nature of the skin surface, many hydrophilic active nutrients are difficult to enter the skin tissue, so that the pores of the skin can fully absorb the maintenance essence contained in the skin care products. . Therefore, in order to solve the problem that the conventional skin care formula can not effectively percutaneous absorption, the prior art further proposes to use phospholipid to coat the active ingredient to achieve percutaneous absorption, and the phospholipid is immunologically, sensitized and chemically synthesized according to the source. The problem of purification, and the storage conditions are more stringent, and has the threshold of application popularity. In view of the problems of the prior art, in order to solve the problem, the present invention proposes a multi-stage release composite particle containing an amino acid marine active factor peptide, which is composed of natural and essential elements and molecules and has an easy percutaneous absorption. The composite fine particles of the hydrophilic active ingredient are coated to serve as an implementation and basis for improving the above disadvantages. The multi-stage release composite microparticle containing an amino acid-containing marine active factor peptide according to the object of the present invention is mainly characterized in that the multi-stage release composite peptide microparticle comprises a peptide for constructing a multi-stage release composite particle space, and a plurality of An ionic marine active factor ionically chelated with the peptide and an amino acid used to strengthen the composite particle structure.
本發明有關於一種可應用於保養組成物之本發明含胺基酸海洋活性因子胜肽之多段釋放複合微粒,其中該多段釋放複合微粒包含一用於架構多段釋放複合微粒空間之胜肽、複數個用於與該胜肽離子性螯合之離子性海洋活性因子及一用於強化複合微粒架構之胺基酸,其中該胜肽包含複數個胜肽離子基團、複數個胜肽親水基團及複數個胜肽疏水基團,其中利用該胜肽離子基團與離子性海洋活性因子來螯合架構一個微粒空間,該微粒空間為親水性空間用來填置該胺基酸,並透過該胺基酸所提供的氫鍵與胜肽親水基團作用來強化胜肽與離子性海洋活性因子所螯合架構之微粒空間之結構,該胜肽疏水基團會在該多段釋放複合微粒外圍形成一個疏水特性區域。 The invention relates to a multi-stage release composite particle of the amino acid-containing marine active factor peptide of the present invention which can be applied to a maintenance composition, wherein the multi-stage release composite particle comprises a peptide for constructing a multi-stage release composite particle space, a plurality An ionic marine active factor for ionic chelation with the peptide and an amino acid for reinforcing the composite microparticle structure, wherein the peptide comprises a plurality of peptide ionic groups, a plurality of peptide hydrophilic groups And a plurality of peptide hydrophobic groups, wherein the peptide ion group and the ionic ocean active factor are used to chelate a particle space, wherein the particle space is a hydrophilic space for filling the amino acid and The hydrogen bond provided by the amino acid interacts with the hydrophilic group of the peptide to enhance the structure of the particle space of the chelation structure of the peptide and the ionic marine active factor, and the hydrophobic group of the peptide will form on the periphery of the multi-stage release composite particle. A hydrophobic property area.
本發明更揭示一種含胺基酸海洋活性因子胜肽之微針型多段釋放複合微粒,其中該多段釋放複合微粒包含一用於架構多段釋放複合微粒空間之胜肽、複數個用於與該胜肽離子性螯合之離子性海洋活性因子、一用於強化複合微粒架構之胺基酸及複數個分佈於該多段釋放複合微粒外圍的微針,其中該胜肽包含複數個胜肽離子基團、複數個胜肽親水基團及複數個胜肽疏水基團,其中利用該胜肽離子基團與離子性海洋活性因子來螯合架構一個微粒空間,該微粒空間為親水性空間用來填置該胺基酸,並透過該胺基酸所提供的氫鍵與胜肽親水基團作用來強化胜肽與離子性海洋活性因子所螯合架構之微粒空間之結構,該胜肽疏水基團會在該多段釋放複合微粒 外圍形成一個疏水特性區域,該微針均勻分佈於該疏水特性區域。 The invention further discloses a microneedle-type multi-segment release composite particle containing an amino acid marine active factor peptide, wherein the multi-stage release composite particle comprises a peptide for constructing a multi-stage release composite particle space, and the plurality of particles are used for the victory a peptide ion-chelating ionic marine active factor, an amino acid for reinforcing the composite particle structure, and a plurality of microneedles distributed around the periphery of the multi-stage release composite particle, wherein the peptide comprises a plurality of peptide ionic groups a plurality of peptide hydrophilic groups and a plurality of peptide hydrophobic groups, wherein the peptide ion group and the ionic ocean active factor are used to chelate a particle space, wherein the particle space is a hydrophilic space for filling The amino acid, through the hydrogen bond provided by the amino acid and the hydrophilic group of the peptide to enhance the structure of the particle space of the chelation structure of the peptide and the ionic marine active factor, the peptide hydrophobic group Release of composite particles in the multi-stage The periphery forms a hydrophobic characteristic region, and the microneedles are uniformly distributed in the hydrophobic characteristic region.
特別是有關於一種利用離子性海洋活性因子與膠原胜肽透過分子設計製成具有離子性複合結構的複合微粒。台灣四周環海,海水資源極為豐富,尤其以台灣的東海岸地形最為特殊,因板塊擠壓造成一陡峭險峻之地理環境,經海洋學家認定具有開發「深層海水」資源之潛力。國際間認定,斜溫層以下的海水(深度>200公尺)即稱為「深層海水」,此深度因陽光終年無法直射,海洋生物數量減少,使得可供這些生物利用的營養份獲得比較多的保留。經分析後證實具有低溫、富含礦物質(微量元素)及營養鹽、清澈乾淨、病原菌極少等優勢,特性有別於一般表層海水,其應用廣泛,是一種具多元利用價值的新興水資源。深層海水中雖含有多種人體所需攝取之微量元素(鐵、鋅、鉬、錳、鋰、鍶、銅、矽)。各種微量元素在人體扮演重要角色,例如鐵(Fe)缺乏會影響氧氣儲存與輸送;鋅(Zn)則與體內免疫調節有關;鋅(Zn)與銅(Cu)與體內醣類、蛋白質與脂質代謝有關;銅(Cu)與硒(Se)則與體內抗氧化能力有關。本發明含胺基酸海洋活性因子胜肽之多段釋放複合微粒,其主要關鍵成份離子性海洋活性因子係由深層海洋深層礦物質水體精製而成並去除過量的鈉離子,特別是使用澳洲大堡礁或台灣東海岸海洋深層礦物質水體,是一種海源性(Ocean-based)礦物質水體,優勢在於洋流可協助來自不同地域的水體所匯集之礦物質與微量元素,作較為均衡之混合。這將有別於一般陸地礦泉水水體會因地理環境差異與自行添加調製的礦物質溶液所會產生成份不均衡的問題,而提供多樣的礦物質與微量元素。不均衡的礦物質攝取將會引發其他礦物質之代謝異常。例如:補充過量的鎂離子,則會產生腹瀉或導致身體磷酸鹽的流失,且補充過多鎂 離子也會連同影響體內鐵和鋅離子的吸收;補充過量之鋅離子時會降低銅離子的吸收率;鉻離子攝取過多,會降低鐵離子與輸鐵蛋白之結合等負面效應。總之,本發明選用海水深層礦物質水體來達成發明之目的,特別是澳洲大堡礁海洋深層水或台灣東海岸海洋深層水水體液擁有天然、潔淨與種類多元之礦物質與微量元素優勢。本發明係利用海水深層礦物質水體作為關鍵成份,在於可提供組織與細胞平衡且均勻的海洋活性輔助因子,並進一步結合多段控制釋放技術,可提供組織與細胞更有效率及持續的修復與維護。 In particular, there is a composite particle having an ionic composite structure by using an ionic marine active factor and a collagen peptide through molecular design. Surrounded by the sea, Taiwan is rich in sea water resources. In particular, Taiwan's east coast topography is the most special. Due to the steep and steep geographical environment caused by plate extrusion, it is recognized by oceanographers as having the potential to develop "deep seawater" resources. It is internationally recognized that seawater below the ramp (depth > 200 m) is called "deep seawater". This depth is not directly exposed to sunlight throughout the year, and the number of marine organisms is reduced, making the nutrients available to these organisms more available. Reservation. After analysis, it has the advantages of low temperature, rich minerals (microelements) and nutrient salts, clear and clean, few pathogenic bacteria, and its characteristics are different from ordinary surface seawater. It is widely used and is an emerging water resource with multiple utilization value. Although deep seawater contains a variety of trace elements (iron, zinc, molybdenum, manganese, lithium, strontium, copper, strontium) that the human body needs to ingest. Various trace elements play an important role in the human body. For example, iron (Fe) deficiency affects oxygen storage and transport; zinc (Zn) is involved in immune regulation in the body; zinc (Zn) and copper (Cu) and carbohydrates, proteins and lipids in the body Metabolism is related; copper (Cu) and selenium (Se) are related to antioxidant capacity in the body. The multi-stage release composite particle containing the amino acid marine active factor peptide of the invention, the main key component of the ionic marine active factor is refined from the deep ocean deep mineral water body and removes excess sodium ion, especially using the Great Barrier Reef of Australia Or the deep mineral water body on the east coast of Taiwan is a sea-based mineral water body. The advantage is that the ocean current can assist the minerals and trace elements collected by water bodies from different regions to be a more balanced mixture. This will be different from the problem that the general terrestrial mineral water body will produce a variety of minerals and trace elements due to the geographical imbalance and the mineral composition of the self-added mineral solution. Unbalanced mineral uptake will trigger metabolic abnormalities in other minerals. For example, replenishing excess magnesium ions can cause diarrhea or lead to loss of phosphate in the body and supplement with excessive magnesium. Ions will also affect the absorption of iron and zinc ions in the body; supplementation of excess zinc ions will reduce the absorption rate of copper ions; excessive intake of chromium ions will reduce the negative effects of the combination of iron ions and transferrin. In summary, the present invention selects a deep seawater mineral water body to achieve the purpose of the invention, in particular, the deep water of the Great Barrier Reef in Australia or the deep water body fluid of the east coast of Taiwan has the advantages of natural, clean and diverse minerals and trace elements. The invention utilizes deep seawater mineral water as a key component, and provides a balanced and uniform marine active cofactor of tissue and cells, and further combines multi-segment controlled release technology to provide more efficient and continuous repair and maintenance of tissues and cells. .
本發明含胺基酸海洋活性因子胜肽之多段釋放複合微粒,其主要特徵在於該多段釋放複合胜肽微粒包含一用於架構多段釋放複合微粒空間之胜肽、複數個用於與該胜肽離子性螯合之離子性海洋活性因子及一用於強化複合微粒架構之胺基酸。本發明中所述之胜肽種類係選自由魚膠原胜肽、藻類膠原胜肽、豬膠原胜肽、牛膠原胜肽、膠原胜肽、植物性膠原胜肽及該等膠原胜肽分解胜肽所組成族群之組合,而胺基酸亦由上述膠原胜肽分子而成。正常人體皮膚中的膠原胜肽會因為年齡及各種不同原因而逐漸流失,而身體製造膠原胜肽及膠原蛋白的速度卻遠遠追不上消耗的速度。本發明所設計關鍵為設計含胺基酸海洋活性因子胜肽之多段釋放複合微粒,多段提供人體組織所需的胺基酸、胜肽及微量元素。因此,本發明透過分子設計亦結合另一個關鍵成份即海洋深層礦物質水體,特別地是利用澳洲大堡礁海洋深層水或台灣東海岸海洋深層水水體。這些水體所含豐富均衡的微量元素與礦物質對皮膚的鎮定、抑菌、消炎、排毒、美顏、抗衰老、提高免疫能力及人體細胞組織代謝修復都有重要的作用與功效。本發明含 胺基酸海洋活性因子胜肽之多段釋放複合微粒,優選地,可進一步包含複數個維生素成份或半胱胺酸衍生物,該維生素成份係選自由維生素C、維生素B1、維生素B2、維生素B3、維生素B5、維生素B6、維生素B7、維生素B9、維生素B12及其組合。半胱胺酸衍生物則選自由各種烷基取代之半胱胺酸、各種烷基取代之半胱胺酸鹽及其組合。所述半胱胺酸衍生物能阻斷或干擾位於表皮及真皮相交的基底層中黑色素細胞的生成機制。當皮膚中的黑色素細胞受到紫外線照射時,就會加速製造酪氨酸酶,而酪氨酸酶就會刺激基底層的酪氨酸氧化成為黑色素。所述的半胱胺酸衍生物能與酪氨酸競爭,並且其較酪氨酸更容易被氧化,因此能透過競爭機制避免黑寧色素生成。複數個維生素成份之維生素C是極佳的抗氧化劑,可避免酪氨酸被氧化成黑色素,為抑制黑色素生成的重要成分,也可以輔助半胱胺酸衍生物抑制黑色素生成。本發明含胺基酸海洋活性因子胜肽之多段釋放複合微粒可以被使用作為凝膠型、水包油型乳化型或油包水型乳化型皮膚保養組合物、化妝品或外用劑之關鍵功能性成份。意即本發明另揭示一種含胺基酸海洋活性因子胜肽之多段釋放複合微粒保養組合物,其中該多段釋放複合微粒保養組合物包含一容器,該容器具有一容置空間;一用於架構多段釋放複合微粒空間之胜肽;複數個用於與該胜肽離子性螯合之離子性海洋活性因子;一用於強化複合微粒架構之胺基酸;以及一分散媒介體,其中該胜肽包含複數個胜肽離子基團、複數個胜肽親水基團及複數個胜 肽疏水基團,其中利用該胜肽離子基團與離子性海洋活性因子來螯合架構一個微粒空間,該微粒空間為親水性空間用來填置該胺基酸,並透過該胺基酸所提供的氫鍵與胜肽親水基團作用來強化胜肽與離子性海洋活性因子所螯合架構之微粒空間之結構,該胜肽疏水基團會在該多段釋放複合微粒外圍形成一個疏水特性區域;該容置空間用於置入該多段釋放複合微粒及該分散媒介體,該多段釋放複合微粒及該分散媒介體在置入容置空間之前會均勻地混合;以及該分散媒介體係選自由凝膠、顆粒懸浮液、均勻液、乳化液、膠囊填充液、微晶成形液、微膠囊成形液、錠劑賦形劑、醫美療程鎮定修護液、保濕美白填充劑、面膜充填液、機能敷料性充填物、膏狀物、油脂、揮發性溶媒、氣體載劑及其組合等所組成之族群。 The multi-stage release composite microparticle containing the amino acid marine active factor peptide of the present invention is mainly characterized in that the multi-stage release composite peptide microparticle comprises a peptide for constructing a multi-stage release composite particle space, and a plurality of peptides for use with the peptide Ionic chelated ionic marine active factor and an amino acid used to strengthen the composite particulate structure. The peptide type described in the present invention is selected from the group consisting of fish collagen peptide, algal collagen peptide, porcine collagen peptide, bovine collagen peptide, collagen peptide, plant collagen peptide and the collagen peptide decomposition peptide A combination of the constituent groups, and the amino acid is also formed from the above-mentioned collagen peptide molecule. Collagen peptides in normal human skin are gradually lost due to age and various reasons, and the speed at which the body produces collagen peptides and collagen is far behind the rate of consumption. The key to the design of the present invention is to design a multi-stage release composite particle containing an amino acid marine active factor peptide, and provide a plurality of amino acids, peptides and trace elements required for human tissues. Therefore, the present invention also incorporates another key component, the deep ocean mineral water, through molecular design, in particular, the use of the deep water of the Great Barrier Reef in Australia or the deep water of the ocean on the east coast of Taiwan. These water bodies contain rich and balanced trace elements and minerals which have important effects and functions on skin stabilization, bacteriostatic, anti-inflammatory, detoxification, beauty, anti-aging, immune enhancement and metabolism of human cells. The invention includes The multi-stage release composite microparticle of the amino acid marine active factor peptide, preferably further comprising a plurality of vitamin components or cysteine derivatives selected from the group consisting of vitamin C, vitamin B1, vitamin B2, vitamin B3, Vitamin B5, vitamin B6, vitamin B7, vitamin B9, vitamin B12 and combinations thereof. The cysteine derivative is then selected from the group consisting of various alkyl substituted cysteamines, various alkyl substituted cysteamines, and combinations thereof. The cysteine derivative can block or interfere with the mechanism of melanogenesis in the basal layer where the epidermis and dermis intersect. When the melanocytes in the skin are exposed to ultraviolet light, the production of tyrosinase is accelerated, and tyrosinase stimulates the tyrosine oxidation of the basal layer to melanin. The cysteine derivative competes with tyrosine and is more susceptible to oxidation than tyrosine, thereby preventing the formation of black pigment by a competitive mechanism. Vitamin C, which is a multivitamin ingredient, is an excellent antioxidant that prevents tyrosine from being oxidized to melanin. It is an important component that inhibits melanin production and also helps cysteine derivatives inhibit melanin production. The multi-stage release composite microparticle containing the amino acid marine active factor peptide of the present invention can be used as a key functionality of a gel type, an oil-in-water type emulsified type or a water-in-oil type emulsified skin care composition, a cosmetic or an external preparation. Ingredients. That is, the present invention further discloses a multi-stage release composite microparticle maintenance composition containing an amino acid marine active factor peptide, wherein the multi-stage release composite microparticle maintenance composition comprises a container having an accommodation space; a multi-stage release peptide of the composite particle space; a plurality of ionic marine active factors for ionic chelation with the peptide; an amino acid for reinforcing the composite particle structure; and a dispersion medium, wherein the peptide Containing a plurality of peptide ionic groups, a plurality of peptide hydrophilic groups, and a plurality of wins a peptide hydrophobic group, wherein the peptide ionic group and the ionic marine active factor are used to sequester a particle space, wherein the particle space is a hydrophilic space for filling the amino acid and passing through the amino acid The hydrogen bond is provided to interact with the hydrophilic group of the peptide to enhance the structure of the particle space of the chelation structure of the peptide and the ionic marine active factor, and the hydrophobic group of the peptide forms a hydrophobic characteristic region around the multi-stage release composite particle. The accommodating space is for inserting the multi-stage release composite particles and the dispersion medium, the multi-stage release composite particles and the dispersion medium are uniformly mixed before being placed in the accommodating space; and the dispersion medium system is selected from the group consisting of Glue, particle suspension, homogeneous liquid, emulsion, capsule filling liquid, microcrystalline forming liquid, microcapsule forming liquid, tablet excipient, medical beauty treatment, calming repairing liquid, moisturizing whitening filling agent, facial mask filling liquid, function A group of dressing fillers, pastes, oils, volatile solvents, gaseous carriers, combinations thereof, and the like.
本發明延伸地揭示一種含胺基酸海洋活性因子胜肽之微針型多段釋放複合微粒保養組合物,其中該微針型多段釋放複合微粒保養組合物包含一容器,該容器具有一容置空間;一用於架構多段釋放複合微粒空間之胜肽;複數個用於與該胜肽離子性螯合之離子性海洋活性因子;一用於強化複合微粒架構之胺基酸;複數個微針;以及一分散媒介體,其中該胜肽包含複數個胜肽離子基團、複數個胜肽親水基團及複數個胜肽疏水基團,其中利用該胜肽離子基團與離子性海洋活性因子來螯合架構一個微粒空間,該微粒空間為親水性空間用來填置該胺基酸,並透過該胺基酸所提供的氫鍵與胜肽親水基團作用來強化胜肽與離子性海洋活性因子所螯合架構之微粒空間之結構,該胜肽疏水基團會在該多段釋放複合微粒 外圍形成一個疏水特性區域;該容置空間用於置入該多段釋放複合微粒及該分散媒介體,該多段釋放複合微粒及該分散媒介體在置入容置空間之前會均勻地混合;該微針係利用具有骨針與海綿絲之淡水海綿體之組織精製而成;及該分散媒介體係選自由凝膠、顆粒懸浮液、均勻液、乳化液、膠囊填充液、微晶成形液、微膠囊成形液、錠劑賦形劑、醫美療程鎮定修護液、保濕美白填充劑、面膜充填液、機能敷料性充填物、膏狀物、油脂、揮發性溶媒、氣體載劑及其組合等所組成之族群。 The present invention extends to disclose a microneedle-type multi-stage release composite microparticle maintenance composition containing an amino acid marine active factor peptide, wherein the microneedle multi-stage release composite microparticle maintenance composition comprises a container having an accommodation space a peptide for constructing a multi-stage release composite particle space; a plurality of ionic marine active factors for ionic chelation with the peptide; an amino acid for strengthening the composite particle structure; a plurality of microneedles; And a dispersing medium, wherein the peptide comprises a plurality of peptide ionic groups, a plurality of peptide hydrophilic groups, and a plurality of peptide hydrophobic groups, wherein the peptide ionic group and the ionic marine active factor are utilized Chelating framework is a particle space, which is a hydrophilic space for filling the amino acid, and strengthens the peptide and ionic marine activity through the hydrogen bond provided by the amino acid and the hydrophilic group of the peptide. The structure of the particle space of the chelation structure of the factor, the hydrophobic group of the peptide will release the composite particle in the multi-stage Forming a hydrophobic characteristic region on the periphery; the accommodating space is for inserting the multi-stage release composite particles and the dispersion medium, and the multi-stage release composite particles and the dispersion medium are uniformly mixed before being placed in the accommodating space; The needle system is refined by using a tissue having a fresh water sponge body of a bone needle and a sponge thread; and the dispersion medium system is selected from the group consisting of a gel, a particle suspension, a uniform liquid, an emulsion, a capsule filling liquid, a microcrystalline forming liquid, and a microcapsule. Forming liquid, tablet excipient, medical beauty treatment, calming and repairing liquid, moisturizing whitening filling agent, facial filling liquid, functional dressing filling, cream, oil, volatile solvent, gas carrier and combination thereof The group of people.
本發明含胺基酸海洋活性因子胜肽之多段釋放複合微粒也可以與水、乙醇及任何可飲用的液體混合調製成健康食品、飲品。當本發明提出含胺基酸海洋活性因子胜肽之多段釋放複合微粒被應用於食品或飲品形態時,其中,該多段釋放複合微粒佔飲品配方0.1~1.0重量百分比。該多段釋放複合微粒內所螯合的離子性活性因子包含複數個選自由鉀、鈣、鐵、鋅、鉬、錳、鋰、鍶、銅、矽或其組合之礦物質。進一步,利用本發明所製成之食品或飲品可包含食品或飲品添加物,其食品或飲品添加物可包含甜味劑、食用色素、營養添加劑、胺基酸、防腐劑、香料、黏稠劑、保色劑、抗氧化劑、調味劑或其組合。在特定的例子中,該甜味劑可包含高果糖糖漿、蔗糖、麥芽糖醇糖漿、寡糖、甜菊糖、乳糖、葡萄糖或其組合物。該營養添加劑可包含維生素C、硫胺、核黃素、煙酸、泛酸、生物素、葉酸、鈷胺素、鹽酸吡哆辛或其組合物。該食用色素可包含紅花黃色素、薑黃素、紅麴素、銅葉綠素鈉、鐵葉綠素鈉、葉黃素或其組合物。該胺基酸可包含精胺酸、離胺酸、甘胺酸、精胺酸、離胺酸、白胺酸、異白胺酸、纈胺酸、 天冬胺酸或其組合物。 The multi-stage release composite microparticles containing the amino acid marine active factor peptide of the present invention can also be mixed with water, ethanol and any drinkable liquid to prepare a health food or drink. When the present invention proposes that the multi-stage release composite microparticle containing the amino acid marine active factor peptide is applied to a food or drink form, the multi-stage release composite particle accounts for 0.1 to 1.0 weight percent of the beverage formulation. The ionic active factor chelated in the multi-stage release composite microparticles comprises a plurality of minerals selected from the group consisting of potassium, calcium, iron, zinc, molybdenum, manganese, lithium, cerium, copper, cerium or combinations thereof. Further, the food or drink prepared by the present invention may comprise a food or drink supplement, and the food or drink supplement may comprise a sweetener, a food coloring, a nutritional additive, an amino acid, a preservative, a fragrance, a thickener, A color retention agent, an antioxidant, a flavoring agent, or a combination thereof. In a particular example, the sweetener can comprise high fructose syrup, sucrose, maltitol syrup, oligosaccharides, stevia, lactose, glucose, or a combination thereof. The nutritional supplement may comprise vitamin C, thiamine, riboflavin, niacin, pantothenic acid, biotin, folic acid, cobalamin, pyridoxine hydrochloride or a combination thereof. The food coloring matter may comprise safflower yellow pigment, curcumin, erythropoietin, copper chlorophyll sodium, iron chlorophyll sodium, lutein or a combination thereof. The amino acid may comprise arginine, lysine, glycine, arginine, lysine, leucine, isoleucine, valine, Aspartic acid or a combination thereof.
本發明一種含胺基酸海洋活性因子胜肽之多段釋放複合微粒,如第1圖、第2圖與第3圖所示:其中 The invention discloses a multi-stage release composite particle containing an amino acid marine active factor peptide, as shown in FIG. 1 , FIG. 2 and FIG. 3 :
10‧‧‧蓋體 10‧‧‧ cover
20‧‧‧容器體 20‧‧‧ container body
30‧‧‧容器體開口 30‧‧‧ container opening
35‧‧‧可折開式容器體開口 35‧‧‧Foldable container body opening
40‧‧‧容置空間 40‧‧‧ accommodating space
50‧‧‧蓋體螺紋 50‧‧‧ cover thread
55‧‧‧螺接部 55‧‧‧ screw joint
100‧‧‧含膠原胜肽複合海洋活性輔助因子 100‧‧‧Collagen peptide-compounding marine active cofactor
200‧‧‧分散媒介體 200‧‧‧Distributed media
300‧‧‧機能性花草成份 300‧‧‧ functional flower ingredients
1000‧‧‧胜肽疏水基團 1000‧‧‧ peptide hydrophobic group
2000‧‧‧胜肽親水基團 2000‧‧‧ peptide hydrophilic group
3000‧‧‧胜肽離子基團 3000‧‧‧ peptide ionic group
4000‧‧‧離子型海洋活性因子 4000‧‧‧Ionic marine active factor
5000‧‧‧胺基酸 5000‧‧‧Amino acid
6000‧‧‧微粒空間 6000‧‧‧Particle space
7000‧‧‧疏水特性區域 7000‧‧‧hydrophobic area
8000‧‧‧微針 8000‧‧‧microneedle
第1圖,本發明一種含胺基酸海洋活性因子胜肽之多段釋放複合微粒立體結構示意圖。 Fig. 1 is a schematic view showing the three-dimensional structure of a multi-stage release composite particle containing an amino acid marine active factor peptide.
第2圖,本發明一種含胺基酸海洋活性因子胜肽之微針型多段釋放複合微粒示意圖。 Fig. 2 is a schematic view showing a microneedle type multi-stage release composite particle containing an amino acid marine active factor peptide.
第3圖,本發明一種含胺基酸海洋活性因子胜肽之多段釋放複合微粒之保養產品應用示意圖。 Fig. 3 is a schematic view showing the application of a maintenance product of a multi-stage release composite particle containing an amino acid marine active factor peptide.
本發明揭示一種含胺基酸海洋活性因子胜肽之多段釋放複合微粒100,如第1圖所示,尤其包含一種可以在透過分散媒介體分散於肌膚提供肌膚養護效果又可同時達到具有鎮定肌膚功效的保養活性複合微粒。本發明含胺基酸海洋活性因子胜肽之多段釋放複合微粒100主要特徵在於該多段釋放複合胜肽微粒包含一用於架構多段釋放複合微粒空間之胜肽、複數個用於與該胜肽離子性螯合之離子性海洋活性因子及一用於強化複合微粒架構之胺基酸,其中該胜肽之胜肽離子基團3000與離子性海洋活性因子4000螯合架構一個多段釋放複合微粒空間,該微粒空間具有親水性用來填置該胺基酸5000,並透過該胺基酸所提供的氫鍵與胜肽親水基團2000作用來強化胜肽與離子性海洋活性因子所螯合架構多段釋放複合微粒空間之結 構。本發明的設計在於透過分子設計架構一多段釋放複合微粒空間,並利用胜肽鍵、氫鍵及離子鍵使該多段釋放複合微粒空間6000形成一個親水性空間,可容納親水性成份。該多段釋放複合微粒之胜肽疏水基團2000會形成一個疏水特性區域7000。本發明多段釋放複合微粒在製備時,可透過粒徑分析儀及動態光散射儀監控來得知微粒形成條件,並可透過螢光標定分子與螢光光譜分析技術以及黏度分析技術來佐證該形成條件,進一步依據實驗所得的形成條件來製作多段釋放複合微粒。粒徑分析可直接且清楚顯示該微粒逐漸成型的經過及粒徑變化。粒徑分析儀與動態光散射儀都可用來分析得到最小複合微粒形成條件,在適當的成型條件下,不論粒徑分析儀與動態光散射儀量測結果都會出現明顯的強度變化。這樣的條件,利用螢光標定分子與螢光光譜分析技術中導入系統螢光監控因子來分析系統激發雙體螢光放射強度對單體螢光放射強度比值(IE/IM),可對比得到多段釋放複合微粒之微環境親疏水特性,在複合微粒形成時,所述激發雙體螢光放射強度對單體螢光放射強度比值(IE/IM)會出現數據折點。本發明所設計的複合微粒,係將大部分的陽離子型離子性海洋活性因子會與多胜肽上的陰離子酸基進行離子性螯合,在這螯禾過程中正負電性會因而中和,導電度也會大幅度改變,導電度改變的轉折點即是最適化的複合微粒形成條件。進一步,本發明透過分子設計概念導入由多胜肽所分解而得的胺基酸,這些胺基酸在離子性螯合反應後導入,這些第二階段導入的胺基酸因其親水性質可散佈於複合微粒內部的親水空間,已降低系統界面活性。在複合微粒內部的親水空間中的胺基酸進一步提供胺基基團與酸基基團,這樣的基團會與多胜肽的胜肽鍵產生氫鍵,使該複合微粒結構更加穩固。利用本 實施例所製備之複合微粒,其外圍具有疏水性特徵。當該複合微粒被加入保養組成物之系統並與組織接觸時,特別是在和皮膚表層接觸時,該疏水外圍因界面能量安定的緣故,會與皮膚表層疏水基團作用,並使複合微粒在穿透表層過程中崩解,並離散出該海洋活性因子與胺基酸,特別是可將該海洋活性因子與胺基酸傳遞到親水性的組織區域。這樣的崩解過程涉及到疏水性作用力與螯合離子鍵、氫鍵之間力的轉移,也因力平衡的連續性緩慢轉移,使該海洋活性因子與胺基酸持續且多段地由複合微粒釋出。同樣地在體內許多的吸收環境,都必須先經過疏水性障壁方能進入親水空間,這些崩解後的離子性海洋活性因子、胺基酸甚至胜肽都是體內新陳代謝及組織修復的關鍵成份。特別是,離子性海洋活性因子是人體生化反應活性之關鍵輔助因子,更是重要。本發明複合微粒包含有豐富的離子性海洋活性因子,而主要是由深層海水所提取之離子性礦物質與微量元素所構成。深層海洋因為陽光無法直射(兩百公尺以下),導致生物量較淺層海水區域少,因此離子性海洋活性因子如礦物質與微量元素的生物消耗性會對較小,深層海水相對會比淺層海水含較豐富的營養鹽類,比陸地的淡水含有更豐富的礦物質與微量元素,例如含有豐富鈉(Na)、鈣(Ca)、鉀(K)、鐵(Fe)、鋅(Zn)、鉬(Mo)、錳(Mn)、鋰(Li)、鍶(Sr)、銅(Cu)、矽(Si)或其組合之微量元素。深層海水可取自海平面下兩百公尺至一千五百公尺之預定深度的海水,較佳可為海平面下五百公尺至七百公尺之預定深度之海水,更特別地,該離子性海洋活性輔助因子是取自利用澳洲大堡礁海洋深層礦物質水體或台灣東海岸海洋深層礦物質水體所精製提煉而成,而胜肽種類的使用並無特別限制,可視其目的適當地選擇,優選地該胜肽係使用膠原胜 肽,可選自由魚膠原胜肽、藻類膠原胜肽、豬膠原胜肽、牛膠原胜肽、膠原胜肽、植物性膠原胜肽及該等膠原胜肽分解胜肽所組成族群之組合。進一步,該胺基酸可包含選自由甘胺酸、纈草胺酸、白胺酸、異白胺酸、丙胺酸、精胺酸、麩醯胺、賴胺酸、天冬醯胺酸、麩醯胺酸、脯胺酸、半胱胺酸、息寧胺酸、甲硫胺酸、組胺酸、苯丙胺酸、酪胺酸、色胺酸、天冬醯胺、甘胺酸、絲胺酸及其組合之胺基酸。透過胺基酸的添加可強化複合性微粒結構,並可提供結構在組織吸收過程中逐步釋放並提供組織多段吸收與持續修護代謝的功效。 The invention discloses a multi-stage release composite microparticle 100 containing an amino acid marine active factor peptide, as shown in FIG. 1 , which particularly comprises a skin which can be dispersed in the skin through a dispersion medium to provide skin care effect and at the same time achieve calm skin. Effective maintenance of active composite particles. The multi-stage release composite microparticle 100 containing the amino acid marine active factor peptide of the present invention is mainly characterized in that the multi-stage release composite peptide microparticle comprises a peptide for constructing a multi-stage release composite particle space, and a plurality of peptides for use with the peptide a chelated ionic marine active factor and an amino acid for enhancing the composite microparticle structure, wherein the peptide agonist group 3000 and the ionic marine active factor 4000 chelate structure are a multi-stage release composite particle space, The particulate space is hydrophilic to fill the amino acid 5000, and the hydrogen bond provided by the amino acid interacts with the peptide hydrophilic group 2000 to enhance the chelation structure of the peptide and the ionic marine active factor. Release the knot of the composite particle space Structure. The design of the present invention is to release the composite particle space through a plurality of stages through the molecular design framework, and use the peptide bond, the hydrogen bond and the ionic bond to make the multi-stage release composite particle space 6000 form a hydrophilic space, and can accommodate the hydrophilic component. The multi-segment release complex particle of the peptide hydrophobic group 2000 forms a hydrophobic characteristic region 7000. In the preparation of the multi-stage release composite particles of the invention, the particle formation conditions can be known through the particle size analyzer and the dynamic light scattering instrument, and the formation conditions can be confirmed by the fluorescence cursor characterization and fluorescence spectroscopy and viscosity analysis techniques. Further, the multi-stage release composite particles are produced according to the formation conditions obtained by the experiment. The particle size analysis can directly and clearly show the gradual formation of the particles and the change in particle size. Both the particle size analyzer and the dynamic light scattering instrument can be used to analyze the minimum composite particle formation conditions. Under appropriate molding conditions, significant changes in intensity can be observed regardless of the particle size analyzer and the dynamic light scattering instrument. Under such conditions, the fluorescence fluorescence intensity of the system is analyzed by using the fluorescence calibration factor of the fluorescent cursor and the fluorescence spectrum monitoring technology to analyze the ratio of the excited fluorescence intensity of the system to the fluorescence intensity of the monomer (IE/IM). The microenvironmental hydrophobicity characteristic of the composite microparticles is released, and when the composite microparticles are formed, a data break point occurs in the ratio of the excited twin fluorescent radiation intensity to the monomer fluorescence emission intensity (IE/IM). The composite microparticles designed by the invention ionicly chelate most of the cationic ionic marine active factors with the anionic acid groups on the polypeptide, and the positive and negative electric properties are neutralized during the chelating process, and the conductive The degree will also change greatly, and the turning point of the change in conductivity is the optimum condition for forming composite particles. Further, the present invention introduces an amino acid which is decomposed by a multi-peptide by a molecular design concept, and these amino acids are introduced after an ionic chelation reaction, and the amino acids introduced in the second stage can be dispersed due to their hydrophilic properties. The hydrophilic space inside the composite particles has reduced system interfacial activity. The amino acid in the hydrophilic space inside the composite microparticle further provides an amine group and an acid group, such a group will generate a hydrogen bond with the peptide bond of the polypeptide, making the composite particle structure more stable. Use this The composite microparticles prepared in the examples have hydrophobic characteristics on the periphery. When the composite microparticles are added to the system of the maintenance composition and are in contact with the tissue, especially when in contact with the surface layer of the skin, the hydrophobic periphery acts on the surface hydrophobic layer of the skin due to the interfacial energy stability, and the composite microparticles are Disintegrating during the penetration of the surface layer, and discarding the marine active factor and the amino acid, in particular, transferring the marine active factor and the amino acid to the hydrophilic tissue region. Such a disintegration process involves the transfer of the force between the hydrophobic interaction and the chelating ionic bond, the hydrogen bond, and the slow transfer of the balance of the force balance, so that the marine active factor and the amino acid are continuously and multi-stagely compounded. The particles are released. Similarly, many absorption environments in the body must first enter the hydrophilic space through the hydrophobic barrier. These disintegrated ionic marine active factors, amino acids and even peptides are the key components of metabolism and tissue repair in the body. In particular, ionic marine active factors are key contributors to human biochemical reactivity and are even more important. The composite microparticles of the invention comprise abundant ionic marine active factors, and are mainly composed of ionic minerals and trace elements extracted from deep seawater. Because the deep ocean cannot directly direct sunlight (below two hundred meters), the biomass is less than the shallow seawater area. Therefore, the bio-consumption of ionic marine active factors such as minerals and trace elements will be smaller, and the deep seawater will be relatively more Shallow seawater contains rich nutrients, which are richer in minerals and trace elements than terrestrial fresh water, such as rich in sodium (Na), calcium (Ca), potassium (K), iron (Fe), and zinc ( Trace elements of Zn), molybdenum (Mo), manganese (Mn), lithium (Li), strontium (Sr), copper (Cu), cerium (Si) or combinations thereof. The deep seawater may be taken from seawater at a predetermined depth of between 200 and 1,500 meters below sea level, preferably at a predetermined depth of 500 to 700 meters below sea level, more particularly The ionic marine active cofactor is obtained by refining the deep mineral water of the Great Barrier Reef in Australia or the deep mineral water of the East Coast of Taiwan. The use of the peptide species is not particularly limited, and may be appropriate according to its purpose. Selectively, preferably the peptide system uses collagen to win The peptide may be selected from the group consisting of a fish collagen peptide, an algal collagen peptide, a porcine collagen peptide, a bovine collagen peptide, a collagen peptide, a plant collagen peptide, and a group of the collagen peptide peptides. Further, the amino acid may comprise selected from the group consisting of glycine, humative, leucine, isoleucine, alanine, arginine, glutamine, lysine, aspartic acid, bran Proline, valine, cysteine, cyanidin, methionine, histidine, phenylalanine, tyrosine, tryptophan, aspartame, glycine, serine And a combination of amino acids. The addition of amino acid can strengthen the composite microparticle structure, and can provide the structure to gradually release during tissue absorption and provide multi-stage absorption and continuous repair metabolism.
本發明第2實施例揭示一種含胺基酸海洋活性因子胜肽之微針型多段釋放複合微粒,如第2圖所示,尤其包含一種可以在透過分散媒介體分散於肌膚提供肌膚養護效果又可同時達到具有肌膚表層微創功效的微針型多段釋放複合微粒。本發明第2實施例含胺基酸海洋活性因子胜肽之微針型多段釋放複合微粒主要特徵在於該多段釋放複合胜肽微粒包含一用於架構多段釋放複合微粒空間之胜肽、複數個用於與該胜肽離子性螯合之離子性海洋活性因子、一用於強化複合微粒架構之胺基酸以及分散於該多段釋放複合胜肽微粒外層之微針,其中該胜肽之胜肽離子基團3000與離子性海洋活性因子4000螯合架構一個多段釋放複合微粒空間,該微粒空間具有親水性用來填置該胺基酸5000,並透過該胺基酸所提供的氫鍵與胜肽親水基團2 000作用來強化胜肽與離子性海洋活性因子所螯合架構多段釋放複合微粒空間6000之結構。本發明的設計在於透過分子設計架構一多段釋放複合微粒空間6000,並利用胜肽鍵、胜肽親水基團2000、氫鍵及離子鍵使該多段釋放複合微粒空間6000形成一個親水性空間,可容納親水性成份。該多段釋放複合微粒之胜肽疏水基團1000會形成一個疏水特性區域7000。該微針8000係由具有骨針與海綿絲之微針海綿組織精製而成,達成本發明穿透皮膚,加速皮下血液循環與暢通淋巴速度,深入皮膚深層循環更新膠原蛋白再生,在不傷皮膚的機轉下,自然而讓老化角質去除之設計目的,並且強化離子性海洋活性因子與胺基酸深入組織之功效。優選地,該微針係利用淡水海綿體,如德國多瑙河流域之淡水海綿體。 A second embodiment of the present invention discloses a microneedle-type multi-segment release composite microparticle containing an amino acid marine active factor peptide, as shown in FIG. 2, which particularly comprises a skin maintenance effect which can be dispersed in the skin through a dispersion medium. It can simultaneously achieve micro-needle-type multi-segment release composite particles with minimally invasive skin surface effects. The microneedle-type multi-segment release composite microparticle containing an amino acid marine active factor peptide of the second embodiment of the present invention is mainly characterized in that the multi-stage release composite peptide microparticle comprises a peptide for constructing a multi-stage release composite particle space, and a plurality of uses. An ionic marine active factor ionically chelated with the peptide, an amino acid for enhancing the composite particle structure, and a microneedle dispersed on the outer layer of the multi-stage release complex peptide, wherein the peptide peptide of the peptide The group 3000 and the ionic marine active factor 4000 chelate structure form a multi-stage release composite particle space having a hydrophilicity for filling the amino acid 5000 and transmitting hydrogen bonds and peptides through the amino acid Hydrophilic group 2 000 function to strengthen the structure of the multi-stage release composite particle space 6000 of the chelation structure of the peptide and the ionic marine active factor. The design of the present invention is to release the composite particle space 6000 through a molecular design framework, and use the peptide bond, the peptide hydrophilic group 2000, the hydrogen bond and the ionic bond to make the multi-stage release composite particle space 6000 form a hydrophilic space. It can hold hydrophilic ingredients. The multi-segment release of the peptide hydrophobic peptide 1000 forms a hydrophobic characteristic region 7000. The microneedle 8000 is made of a microneedle sponge tissue having a bone needle and a sponge wire, and achieves the invention to penetrate the skin, accelerate subcutaneous blood circulation and clear lymphatic velocity, and deepen the circulation of the skin to renew collagen regeneration without damaging the skin. The machine is turned down, naturally let the aging keratin remove the design purpose, and strengthen the effect of ionic marine active factor and amino acid deep into the tissue. Preferably, the microneedle system utilizes a freshwater sponge, such as a freshwater sponge in the Danube Valley of Germany.
本發明第3實施例是利用含胺基酸海洋活性因子胜肽之多段釋放複合微粒所製成之保養產品,如第3圖所示,包含一容器、一含胺基酸海洋活性因子胜肽之多段釋放複合微粒100及一分散媒介體。在本發明實施例中該容器包含蓋體10,容器體20以及在該容器體20一端具有向外突出的容器體開口30,以及在容器體內部所具有的容置空間40;容器體開口30外部具有外部螺紋之一螺接部55,而該蓋體10內部具有與外部螺紋相對應內部螺紋之蓋體螺紋50,使該蓋體螺紋50密合於該螺接部55。該容置空間40可置入含胺基酸海洋活性因子胜肽之多段釋放複合微粒100及該分散媒介體200,一 般言,該含胺基酸海洋活性因子胜肽之多段釋放複合微粒100及該分散媒介體200置入容置空間40之前會均勻地混合,形成一種含胺基酸海洋活性因子胜肽之多段釋放複合微粒100與分散媒介體200混合物之保養產品。該含胺基酸海洋活性因子胜肽之多段釋放複合微粒100及其製備如實施例1所述,主要係利用膠原胜肽與海洋海洋深層水加工合成而得,特別地是利用澳洲大堡礁海洋深層水或台灣東海岸深層水。該分散媒介體200選自由凝膠、顆粒懸浮液、均勻液、乳化液、膠囊填充液、微晶成形液、微膠囊成形液、錠劑賦形劑、醫美療程鎮定修護液、保濕美白填充劑、面膜充填液、機能敷料性充填物、膏狀物、油脂、揮發性溶媒、氣體載劑及其組合等所組成之族群。本發明實施例的應用,進一步包含複數個機能性芬香花草成份300,該機能性芬香花草成份300係選自由桂花、決明子、杜仲葉、荷葉、洋甘菊、菩提葉、玫瑰花、紫羅蘭、香蜂葉、馬黛茶、粉玫瑰、馬鞭草、檸檬草、荷葉、菩提子花、薰衣草、香蜂草、茉莉葉、洋甘菊、茉莉花、金盞花、迷迭香、明日葉、玳玳花、毛蕊花、繡線菊、歐石南、金盞花、鼠尾草、岱岱花、川芎、荷葉、芙蓉花、蘋果花、橙花、車菊花、蜜銀花、黃金桂花、甜菊葉、矢車菊所組成族群。在使用本發明實施例的皮膚保養應用情境中,將蓋體10與容器體20分離,開啟該容置空間40,使用者可以透過擠壓軟質容器或傾倒硬質容器,取用置於容納空間之含胺基酸海洋活性因子胜肽之多段釋放複合微粒與分散媒介體混合物,利用噴灑或塗抹或其它能在皮膚上展開之方式,使皮膚能與含胺基酸海洋活性因子胜肽之多段釋放複合微粒充份接觸,並透過本發明之設計,穿過疏水性皮膚表層,深入組織,在過程中因皮膚表層疏水對多段釋放複合微粒之疏水作用力, 使多段釋放複合微粒在穿越過程中,逐漸崩解,多段並緩釋出所所於結構中的海洋活性因子與胺基酸,使皮膚深層組織充分吸收海洋活性因子與胺基酸,達到海洋活性因子與胺基酸對人體生化代謝與保養修復的功效。該蓋體10亦可以瓶塞取代,除可同樣達到密閉之功效外,更可符合不同使用狀態之所需。本發明一種含胺基酸海洋活性因子胜肽之多段釋放複合微粒,特別地是利用澳洲大堡礁海洋深層礦物質水體或台灣東海岸海洋深層礦物質水體,而胜肽種類的使用並無特別限制,優選地為膠原胜肽,如選自由魚膠原胜肽、藻類膠原胜肽、豬膠原胜肽、牛膠原胜肽、膠原胜肽、植物性膠原胜肽及該等膠原胜肽分解胜肽所組成族群之組合。該多段釋放複合微粒佔多段釋放複合微粒與分散媒介體混合物重量百分率之範圍介於百分之十到百分之六十之間。該分散媒介體特定地可以有重量百分率範圍介於百分之零點五到百分之一點五之間含羥乙基支鏈之修飾纖維素聚合物;重量百分率範圍介於百分之一到百分之五之間的乳化劑;重量百分率範圍介於百分之三到百分之十五的護膚溶劑;重量百分率範圍介於百分之一到百分之十的潤膚劑;重量百分率範圍介於百分之零點五到百分之二十的矽氧烷化合物。該分散媒介體特定地可進一步添加之Q10、蠶絲蛋白、玻尿酸、左旋C、珍珠粉、維生素、半胱胺酸衍生物等機能性輔助成份,其中Q10可以是Co-Q10、輔酵素Q10、輔酶酵素Q10等,蠶絲蛋白可以是蠶絲蛋白肽胺基酸、蠶絲胜肽等,玻尿酸可以是N-乙醯葡萄糖胺(NAG)、葡萄醛酸-N-乙硫氨基葡糖、玻尿酸前驅物等,左旋C可以是左旋維他命C、左式右旋維他命C、維他命C、脂化C等,珍珠粉可以是小分子水解珍珠粉等,維生素成份可以是維生素C、維生素B1、維生素B2、維生素B3、維生素B5、 維生素B6、維生素B7、維生素B9、維生素B12等,半胱胺酸衍生物可以是各種烷基取代之半胱胺酸、各種烷基取代之半胱胺酸鹽,以上各成分並無特別限制,可視其目的適當地選擇。特定地,本發明該分散媒介體可使用矽油作為載劑。例如聚烷基矽氧烷,聚烷基芳香基矽氧烷和聚醚矽氮烷共聚物等。優選地,可使用一選自由聚二甲基矽氧烷、聚(甲基苯基)矽氧烷、氧化烯醚共聚物及其組合之矽油。選擇性地,酯類也可併入本發明分散媒介體作為藥學上可接受的載劑,這些酯類包含10到20個碳原子之脂肪酸的烷基酯、含10到20碳原子之脂肪酸的鏈烯基酯、醚酯化物、多羥基醇酯、蠟酯、固醇酯及其組合之族群。例如脂肪酸的甲基、異丙基、及丁基酯、己基月桂酸鹽、異己基月桂酸鹽、異己基棕櫚酸鹽、異丙基棕櫚酸鹽、癸基油酸鹽、癸基硬脂酸鹽、異癸基油酸鹽、鯨蠟基基硬脂酸鹽、異丙基異硬酯酸鹽、二異丙基己二酸鹽、二異己基己二酸鹽、二己基癸基己二酸鹽、二異丙基癸二酸鹽、十二烷基乳酸鹽、十四烷基乳酸鹽和鯨蠟基基乳酸鹽、油基十四酸鹽、油基硬脂酸鹽和油基油酸鹽、乙氧基化脂醇的脂肪酸酯、乙烯乙二醇單和雙-脂肪酸酯、二乙烯乙二醇單和雙-脂肪酸酯,聚乙烯乙二醇單和雙-脂肪酸酯,丙烯乙二醇單和雙-脂肪酸酯,聚丙烯乙二醇單油酸鹽、聚丙烯乙二醇單硬脂酸鹽、乙氧基化丙烯乙二醇單硬脂酸鹽、丙三基單和雙-脂肪酸酯、多丙三醇多脂肪酸酯、乙氧基化丙三醇單硬脂酸鹽、1,3-丁烯乙二醇單硬脂酸鹽、1,3-丁烯乙二醇二硬脂酸鹽、聚氧化乙烯聚醇脂肪酸酯、脫水山藥醇脂肪酸酯、聚氧化乙烯脫水山梨醇脂肪酸酯、蜂蠟、鯨腦油、十四烷基十四酸鹽、硬脂酸基硬脂酸鹽、膽固醇、脂肪酸酯等。進一步,該分散媒介體次要附屬成分亦可包含防腐劑、芬芳劑、抗起泡劑、 遮光劑、著色劑及其混合物,每項皆以其有效劑量達成其各別的功能。該容器可以是硬質瓶狀容器、軟質管狀容器、硬質罐狀容器等。 A third embodiment of the present invention is a maintenance product made by using a multi-stage release composite microparticle containing an amino acid marine active factor peptide, as shown in Fig. 3, comprising a container, an amino acid-containing marine active factor peptide The plurality of segments release the composite particles 100 and a dispersion medium. In the embodiment of the present invention, the container comprises a lid body 10, a container body 20 and a container body opening 30 protruding outwardly at one end of the container body 20, and an accommodating space 40 provided inside the container body; the container body opening 30 The outer portion has a screw portion 55 of an external thread, and the cover body 10 has a cover thread 50 corresponding to the internal thread corresponding to the external thread, so that the cover thread 50 is in close contact with the screw portion 55. The accommodating space 40 can be placed in the multi-stage release composite particle 100 containing the amino acid marine active factor peptide and the dispersion medium 200, Generally, the multi-stage release composite particle 100 containing the amino acid-containing marine active factor peptide and the dispersion medium 200 are uniformly mixed before being placed in the accommodating space 40 to form a plurality of segments of the amino acid-containing marine active factor peptide. A maintenance product that releases the mixture of the composite microparticles 100 and the dispersion medium 200. The multi-stage release composite microparticle 100 containing the amino acid marine active factor peptide and the preparation thereof are as described in Example 1, and are mainly obtained by using collagen peptide and deep ocean water processing of marine ocean, in particular, utilizing the Great Barrier Reef Ocean Deep water or deep water on the east coast of Taiwan. The dispersion medium 200 is selected from the group consisting of a gel, a particle suspension, a uniform liquid, an emulsion, a capsule filling liquid, a microcrystalline forming liquid, a microcapsule forming liquid, a tablet excipient, a medical treatment, a calming and repairing liquid, and a moisturizing whitening. A group consisting of a filler, a mask filling liquid, a functional dressing filling, a paste, a fat, a volatile solvent, a gas carrier, and combinations thereof. The application of the embodiment of the present invention further comprises a plurality of functional fragrant flowers and plants ingredients 300, wherein the functional fragrant flower and grass ingredients 300 are selected from the group consisting of sweet-scented osmanthus, cassia seed, Eucommia ulmoides, lotus leaves, chamomile, bodhi leaves, roses, violets, incense Bee leaf, mate tea, pink rose, verbena, lemon grass, lotus leaf, linden flower, lavender, lemon balm, jasmine leaf, chamomile, jasmine, calendula, rosemary, tomorrow leaf, silk flower, mullein, Spiraea, arborvitae, calendula, sage, sassafras, chuanxiong, lotus leaf, hibiscus, apple blossom, orange blossom, car chrysanthemum, honeysuckle, gold osmanthus, stevia, cornflower. In the skin care application scenario of the embodiment of the present invention, the cover body 10 is separated from the container body 20, and the accommodating space 40 is opened. The user can insert the soft container or pour the rigid container into the accommodating space. A multi-stage release composite particle containing amino acid marine active factor peptide and a dispersion medium mixture, which can be released from the skin with an amino acid-containing marine active factor peptide by spraying or spreading or other means capable of spreading on the skin. The composite particles are in sufficient contact and, through the design of the present invention, pass through the surface layer of the hydrophobic skin, deep into the tissue, and in the process, due to the hydrophobic interaction of the skin surface layer on the multi-stage release of the composite particles, The multi-segment release composite particles gradually disintegrate during the traversing process, and release the marine active factors and amino acids in the structure in multiple stages, so that the deep tissue of the skin fully absorbs the marine active factors and amino acids to achieve the marine active factors. The effect of amino acid on the biochemical metabolism and maintenance of the human body. The cover 10 can also be replaced by a stopper, and in addition to the sealing effect, it can meet the requirements of different use states. The invention discloses a multi-stage release composite particle containing an amino acid marine active factor peptide, in particular, a deep mineral water body of the Great Barrier Reef in Australia or a deep mineral water body of the east coast of Taiwan, and the use of the peptide type is not particularly limited. , preferably a collagen peptide, such as selected from the group consisting of a fish collagen peptide, an algal collagen peptide, a porcine collagen peptide, a bovine collagen peptide, a collagen peptide, a plant collagen peptide, and the collagen peptide peptide A combination of ethnic groups. The multi-stage release composite particles account for between 10% and 60% by weight of the multi-stage release composite particles and the dispersion medium mixture. The dispersion medium may specifically have a modified cellulose polymer having a hydroxyethyl branch in a weight percentage ranging from 0.5 to 1.5 percent; the weight percentage ranges from one percent to one percent Emulsifier to between 5 percent; skin care solvent in the range of 3 to 15 percent by weight; emollient in weight percent ranging from 1 to 10 percent; weight The percentage ranges from 0.5 to 20 percent of the oxoxane compound. The dispersing medium can be further added with functional auxiliary components such as Q10, silk fibroin, hyaluronic acid, levorotin C, pearl powder, vitamins, and cysteine derivatives, wherein Q10 can be Co-Q10, coenzyme Q10, and coenzyme. Enzyme Q10, etc., silk protein may be silk protein peptide amino acid, silk peptide, etc., hyaluronic acid may be N-acetylglucosamine (NAG), glucuronic acid-N-ethylthioglucosamine, hyaluronic acid precursor, etc. L-C can be L-Vitamin C, L-V-C, Vitamin C, C, etc. Pearl powder can be small molecule hydrolyzed pearl powder, vitamins can be vitamin C, vitamin B1, vitamin B2, vitamin B3, Vitamin B5, The vitamin B6, the vitamin B7, the vitamin B9, the vitamin B12, etc., the cysteine derivative may be various alkyl-substituted cysteine acids and various alkyl-substituted cysteamine salts, and the above components are not particularly limited. Appropriate selection can be made depending on its purpose. Specifically, the dispersion medium of the present invention can use eucalyptus oil as a carrier. For example, polyalkyl siloxane, polyalkyl aryl siloxane and polyether decane copolymer, and the like. Preferably, an eucalyptus oil selected from the group consisting of polydimethyl siloxane, poly(methylphenyl) decane, oxyalkylene ether copolymers, and combinations thereof can be used. Alternatively, the esters may also be incorporated into the dispersion vehicle of the present invention as a pharmaceutically acceptable carrier, the esters comprising an alkyl ester of a fatty acid having 10 to 20 carbon atoms, a fatty acid having 10 to 20 carbon atoms. A group of alkenyl esters, ether esters, polyhydric alcohol esters, wax esters, sterol esters, and combinations thereof. For example, methyl, isopropyl, and butyl esters of fatty acids, hexyl laurate, isohexyl laurate, isohexyl palmitate, isopropyl palmitate, decyl oleate, decyl stearic acid Salt, isodecyl oleate, cetyl stearate, isopropyl isostearate, diisopropyl adipate, diisohexyl adipate, dihexyl decyl hexane Acid salts, diisopropyl sebacate, lauryl lactate, tetradecyl lactate and cetyl lactate, oleyl myristate, oleyl stearate and oil base oil Fatty acid esters of acid salts, ethoxylated fatty alcohols, mono- and di-fatty acid esters of ethylene glycol, mono- and di-fatty acid esters of diethylene glycol, polyethylene glycol mono- and di-fatty acids Ester, propylene glycol mono- and di-fatty acid esters, polypropylene glycol monooleate, polypropylene glycol monostearate, ethoxylated propylene glycol monostearate, C Tribasic mono- and di-fatty acid esters, polyglycerol polyfatty acid esters, ethoxylated glycerol monostearate, 1,3-butene glycol monostearate, 1,3 -butene glycol distearate, poly Oxidized ethylene polyol fatty acid ester, dehydrated yam alcohol fatty acid ester, polyoxyethylene sorbitan fatty acid ester, beeswax, whale oil, tetradecyl myristate, stearic acid stearate, cholesterol , fatty acid esters, and the like. Further, the secondary component of the dispersion medium may also contain a preservative, a fragrance, an anti-foaming agent, Sunscreens, colorants, and mixtures thereof, each of which achieves its individual function in its effective dosage. The container may be a rigid bottle container, a soft tubular container, a rigid can container or the like.
本發明含胺基酸海洋活性因子胜肽之多段釋放複合微粒,具有下述優點:(1)本發明含胺基酸海洋活性因子胜肽之多段釋放複合微粒中各離子比例符合人體組織與細胞所必需。(2)本發明含胺基酸海洋活性因子胜肽之多段釋放複合微粒,具有多種礦物質及微量元素,例如鐵、鋅、鉬、錳、鋰、鍶、銅、矽等微量元素,可在人體生化反應代謝系統中扮演維持活性輔助因子之功能,並配合體內酵素促進人體新陳代謝。 The multi-stage release composite microparticle containing the amino acid marine active factor peptide of the invention has the following advantages: (1) The ratio of each ion in the multi-stage release composite microparticle containing the amino acid-containing marine active factor peptide of the invention conforms to human tissues and cells Required. (2) The multi-stage release composite particle of the amino acid-containing marine active factor peptide of the invention has various minerals and trace elements, such as trace elements such as iron, zinc, molybdenum, manganese, lithium, strontium, copper and strontium, and can be The human biochemical reaction metabolic system plays the role of maintaining an active cofactor and is combined with enzymes in the body to promote human metabolism.
上所述者,僅為本發明之較佳實施例,當不能以此限定本發明實施之範圍,即大凡依本發明申請專利範圍及發明說明書內容所作之等效變化與修飾,皆應仍屬本發明專利涵蓋之範圍內。綜觀上述,本發明之構造特徵確實具有實用價值及進步性,以其整體結構而言,誠已符合專利法之法定要件,爰依法提出發明專利申請。 The above is only the preferred embodiment of the present invention, and the scope of the present invention is not limited thereto, that is, the equivalent changes and modifications made by the scope of the invention and the contents of the invention are still The scope of the invention is covered. Looking at the above, the structural features of the present invention do have practical value and progress. In terms of its overall structure, Cheng has already complied with the statutory requirements of the patent law, and has filed an invention patent application according to law.
10‧‧‧蓋體 10‧‧‧ cover
20‧‧‧容器體 20‧‧‧ container body
30‧‧‧容器體開口 30‧‧‧ container opening
40‧‧‧容置空間 40‧‧‧ accommodating space
100‧‧‧含胺基酸海洋活性因子之多段釋放複合胜肽微粒 100‧‧‧Multi-stage release complex peptide particles containing amino acid marine active factors
200‧‧‧分散媒介體 200‧‧‧Distributed media
300‧‧‧胺基酸 300‧‧‧Amino acid
1000‧‧‧胜肽疏水基團 1000‧‧‧ peptide hydrophobic group
6000‧‧‧微粒空間 6000‧‧‧Particle space
7000‧‧‧疏水特性區域 7000‧‧‧hydrophobic area
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102138235A TW201515666A (en) | 2013-10-23 | 2013-10-23 | Multi-stage releasing composite particles containing amino acid marine active factor peptides and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102138235A TW201515666A (en) | 2013-10-23 | 2013-10-23 | Multi-stage releasing composite particles containing amino acid marine active factor peptides and manufacturing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201515666A true TW201515666A (en) | 2015-05-01 |
Family
ID=53720046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW102138235A TW201515666A (en) | 2013-10-23 | 2013-10-23 | Multi-stage releasing composite particles containing amino acid marine active factor peptides and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW201515666A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10680473B2 (en) | 2016-07-22 | 2020-06-09 | Industrial Technology Research Institute | Electric motor rotor mechanism |
CN115887239A (en) * | 2023-02-16 | 2023-04-04 | 奥伦国际有限公司 | Cosmetic filler segmented release particle structure and dressing carrier |
-
2013
- 2013-10-23 TW TW102138235A patent/TW201515666A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10680473B2 (en) | 2016-07-22 | 2020-06-09 | Industrial Technology Research Institute | Electric motor rotor mechanism |
CN115887239A (en) * | 2023-02-16 | 2023-04-04 | 奥伦国际有限公司 | Cosmetic filler segmented release particle structure and dressing carrier |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101860307B1 (en) | Cosmetic composition for moisturizing skin containing water-soluble silicon | |
CN103565728A (en) | Lycium ruthenicum mill whitening and moisturizing smoothing toner and preparation method of smoothing toner | |
KR20070081192A (en) | Cosmetic composition containing liposome containing oryzanol, rice bran oil and phospholipid as active ingredient | |
CN103494760A (en) | Moistening and whitening facial mask and preparation method thereof | |
CN104983647A (en) | Deep restoration mask and making method thereof | |
CN107693456A (en) | A kind of natural tea pasta frost and preparation method thereof | |
CN109350591A (en) | A kind of U.S. face dried noodle film and preparation method thereof | |
CN105168106A (en) | Three-flower whitening and skin tendering facial mask liquid and preparation method therefor | |
JP5760280B1 (en) | Effervescent skin external preparation | |
TW201515666A (en) | Multi-stage releasing composite particles containing amino acid marine active factor peptides and manufacturing method thereof | |
CN109528536A (en) | A kind of skin care item and preparation method thereof containing choline ellagic acid salt | |
CN101219212A (en) | Eatable face pack for beauty treatment skin-protection and technique of preparing the same | |
CN105456124A (en) | Grape seed whitening mask | |
CN101785752A (en) | Composite nanoemulsion used for epidermis repair and preparation method thereof | |
CN108309919A (en) | Goat Placenta-peptide-bone collagen peptide composition, the facial mask liquid containing the composition | |
CN112675071A (en) | Wool keratin freeze-dried mask and preparation method and application thereof | |
FR2911495A1 (en) | COSMETIC USE OF IRON ASSOCIATIONS FOR SKIN CARE. | |
TWM483081U (en) | Care compositions containing collagen peptides compound marine active cofactor | |
JP2015214537A (en) | Foamable skin external preparation | |
CN112545970B (en) | Pearl cream for beauty and skin care and preparation method thereof | |
RU2210359C1 (en) | Cosmetic agent | |
JP3839390B2 (en) | Cosmetics | |
CN108066275A (en) | A kind of edible rose facial mask and preparation method thereof | |
CN107737035A (en) | One kind nourishes moisture saver mask | |
CN113304098A (en) | Facial mask essence containing stem cell extracting solution and facial mask |